Human medicines European public assessment report (EPAR): Verzenios, abemaciclib, Breast Neoplasms, Date of authorisation: 26/09/2018, Revision: 7, Status: Authorised | Human medicines European public assessment report (EPAR): Verzenios, abemaciclib, Breast Neoplasms, Date of authorisation: 26/09/2018, Revision: 7, Status: Authorised | | Human medicines European public assessment report (EPAR): Refixia, nonacog beta pegol, Hemophilia B, Date of authorisation: 02/06/2017, Revision: 2, Status: Authorised | Human medicines European public assessment report (EPAR): Refixia, nonacog beta pegol, Hemophilia B, Date of authorisation: 02/06/2017, Revision: 2, Status: Authorised | | |